List Of drugs 2014 FDA

fish spelling out Welcome


List Of drugs 2014 FDA


JANUARY

ENTRY1 


Farxiga (dapagliflozin) Tablets

Company: Bristol-Myers Squibb Company and AstraZeneca
Date of Approval: January 8, 2014
Treatment for: Diabetes Type 2
Farxiga (dapagliflozin) is a selective sodium-glucose cotransporter-2 inhibitor for the treatment of adults with type 2 diabetes mellitus.
LINK FOR SYNTHESIS
CLICK HEREhttp://newdrugapprovals.wordpress.com/2013/12/18/dapagliflozin-sees-light/



ENTRY 2

TASIMELTION…FDA Approves Hetlioz: First Treatment for Non-24 Hour Sleep-Wake Disorder in Blind Individuals

Generic Name: tasimelteon
Date of Approval: January 31, 2014
Company: Vanda Pharmaceuticals, Inc.


fish spelling out Welcome


FEBRUARY

ENTRY3
FDA Approves Vimizim to Treat Mucopolysaccharidosis Type IVA
Vimizim (elosufase alfa) is an enzyme replacement therapy for patients with Mucopolysaccharidosis Type IVA (Morquio A syndrome).
Company: BioMarin Pharmaceutical Inc.
Date of FDA Approval: February 14, 2014
Treatment for: Mucopolysaccharidosis Type IVA
LINK
http://newdrugapprovals.org/2014/02/17/fda-approves-vimizim-to-treat-mucopolysaccharidosis-type-iva/



ENTRY 4
Tivorbex (indomethacin); Iroko Pharmaceuticals; For the treatment of acute pain, Approved February of 2014

Tivorbex (indomethacin); Iroko Pharmaceuticals; For the treatment of acute pain,

Tivorbex (indomethacin); Iroko Pharmaceuticals; For the treatment of acute pain, Approved February of 2014
2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid
cas 53-86-1


ENTRY5
Myalept (metreleptin for injection); Bristol-Myers Squibb; For the treatment of congenital or acquired generalized lipodystrophy, Approved February of 2014
The US Food and Drug Administration’s (FDA) Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) has recommended AstraZeneca and Bristol-Myers Squibb’s (BMS) investigational medicine metreleptin for the treatment of paediatric and adult patients with generalised lipodystrophy (LD).
http://newdrugapprovals.org/2013/12/17/fda-panel-recommends-astrazeneca-and-bms-metreleptin-for-generalised-lipodystrophy/



ENTRY6
Imbruvica (ibrutinib); Pharmacyclics; For the treatment of chronic lymphocytic leukemia, Approved February 2014
http://newdrugapprovals.org/2014/02/27/ibrutinib-%E4%BE%9D%E9%B2%81%E6%9B%BF%E5%B0%BC/


ENTRY 7

Northera (droxidopa); Chelsea Therapeutics; For the treatment of neurogenic orthostatic hypotension, Approved February 2014http://newdrugapprovals.org/2013/10/10/chelsea-therapeutics-announces-fda-advisory-committee-to-review-northera/

fish spelling out Welcome










fish spelling out Welcome


ANTHONY MELVIN CRASTO
THANKS AND REGARD’S
DR ANTHONY MELVIN CRASTO Ph.D
GLENMARK SCIENTIST , NAVIMUMBAI, INDIA
did you feel happy, a head to toe paralysed man’s soul in action for you round the clock
need help, email or call me
MOBILE-+91 9323115463
web link
I was  paralysed in dec2007, Posts dedicated to my family, my organisation Glenmark, Your readership keeps me going and brings smiles to my family

No comments:

Post a Comment